Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T00:44:00.821Z Has data issue: false hasContentIssue false

The Epidemiology of Hemorrhage Related to Cardiothoracic Operations

Published online by Cambridge University Press:  02 January 2015

Loreen A. Herwaldt*
Affiliation:
University of Iowa College of Medicine, Departments of Internal Medicine, Iowa City, Iowa University of Iowa Hospitals and Clinics, Iowa City, Iowa Veterans' Administration Medical Center, Iowa City, Iowa
Sheri K. Swartzendruber
Affiliation:
University of Iowa Hospitals and Clinics, Iowa City, Iowa
Michael B. Edmond
Affiliation:
University of Iowa College of Medicine, Departments of Internal Medicine, Iowa City, Iowa
Richard P. Embrey
Affiliation:
University of Iowa College of Medicine, Department of Surgery, Iowa City, Iowa
Kim R. Wilkerson
Affiliation:
University of Iowa Hospitals and Clinics, Iowa City, Iowa
Richard P. Wenzel
Affiliation:
University of Iowa College of Medicine, Departments of Internal Medicine, Iowa City, Iowa University of Iowa Hospitals and Clinics, Iowa City, Iowa
Trish M. Perl
Affiliation:
University of Iowa College of Medicine, Departments of Internal Medicine, Iowa City, Iowa Veterans' Administration Medical Center, Iowa City, Iowa
*
Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242-1081

Abstract

Objective:

To define the epidemiology, risk factors, and unadjusted cost of hemorrhages related to cardiothoracic operations.

Study Design:

We conducted two case-control studies to evaluate the risk of hemorrhage following cardiothoracic operations. The definition of hemorrhage required one of the following: reoperation for bleeding, postoperative loss of greater than 800 mL of blood over 4 hours, or surgeon-diagnosed excessive intraoperative bleeding.

Setting:

The cardiothoracic surgery service of a university hospital.

Results:

Of 511 patients undergoing cardiothoracic operations, 93 (18%) met the definition of hemorrhage. In the first case-control study, 3 (14%) of 21 cases and 0 of 42 controls died (odds ratio [OR], 15.0; 95% confidence interval [CI95], 1.18-191.55). Compared with controls, cases received significantly more packed red blood cells intraoperatively (OR, 1.18/100 mL; CI95, 1.01-1.38), and significantly more platelets (OR, 3.26/100 mL; CI95, 1.47-7.26) and fresh frozen plasma (OR, 1.73/100 mL; CI95, 1.05-.84) in the intensive-care unit. Cases were more likely than controls to receive protamine postoperatively (OR, 3.74; CI95, 1.27-11.02). Previous sternotomy, preoperative aspirin or heparin, and preoperative laboratory values did not predict bleeding. The median unadjusted hospital cost was $3,458 higher for patients who suffered hemorrhage than for controls.

To decrease costs, hetastarch (acquisition cost $45/500 mL) was substituted for albumin (acquisition cost $76/100 mL) in the pump priming solution (estimated possible cost savings, $7,000-$53,000/year). Because hemorrhage rates increased subsequently, we conducted a second case-control study that identified patient age (P=.02) and use of greater than 5 mL/kg of hetastarch (OR, 1.82) as risk factors for hemorrhage. The cost of treating hemorrhages exceeded all estimates of possible cost savings ($7,000-$53,000 per year).

Conclusions:

Our definition of hemorrhage identified patients who required increased volumes of blood products and who had an increased crude mortality rate and a higher unadjusted cost of hospitalization. Patient age and hetastarch use were risk factors for hemorrhage. Efforts to save money by substituting less expensive products inadvertently may increase costs by increasing the probability of perioperative adverse events.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Silber, JH, Rosenbaum, PR, Schwartz, S, Ross, RN, Williams, SV. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA 1995;274:317323.CrossRefGoogle ScholarPubMed
2. Localio, AR, Hamory, BH, Sharp, TJ, Weaver, SL, TenHave, TR, Landis, JR. Comparing hospital mortality in adult patients with pneumonia. A case study of statistical methods in a managed care program. Ann Intern Med 1995;122:125132.CrossRefGoogle Scholar
3. Green, J, Wintfeld, N. Report cards on cardiac surgeons. Assessing New York State's Approach. N Engl J Med 1995;332:1221232.CrossRefGoogle ScholarPubMed
4. Salzman, EW, Weinstein, MJ, Weintraub, RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986;314:14021406.CrossRefGoogle ScholarPubMed
5. Salzman, EW, Weinstein, MJ, Reilly, D, Ware, JA. Adventures in hemostasis. Desmopressin in cardiac surgery. Arch Surg 1993;128:212217.CrossRefGoogle ScholarPubMed
6. Mammen, EF, Koets, MH, Washington, BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Seminars in Thrombosis and Hemostasis 1985;11:281292.CrossRefGoogle ScholarPubMed
7. Ovrum, E, Holen, EA, Abdelnoor, M, Oystese, R. Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. Ann Thorac Surg 1991;52:500505.CrossRefGoogle ScholarPubMed
8. Michelson, EL, Torosian, M, Morganroth, J, MacVaugh, H III. Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. Am J Surg 1980;139:313317.CrossRefGoogle ScholarPubMed
9. Marengo-Rowe, AJ, Lambert, CJ, Leveson, JE, Thiele, JP, Geisler, GF, Adam, M, et al. The evaluation of hemorrhage in cardiac patients who have undergone extracorporeal circulation. Transfusion 1979;19:426433.CrossRefGoogle ScholarPubMed
10. Sethi, GK, Copeland, JG, Moritz, T, Henderson, W, Zadina, K, Goldman, S. Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary artery. Ann Thorac Surg 1991;51:733738.CrossRefGoogle ScholarPubMed
11. Bachmann, F, McKenna, R, Cole, ER, Najafi, H. The hemostatic mechanism after open-heart surgery, I: studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorpo-real circulation. J Thorac Cardiovasc Surg 1975;70:7685.CrossRefGoogle Scholar
12. Craddock, DR, Logan, A, Fadali, A. Reoperation for hemorrhage following cardiopulmonary by-pass. Br J Surg 1968:55;1720.CrossRefGoogle ScholarPubMed
13. Ulicny, KS Jr, Hiratzka, LF, Williams, RB, Grunkemeier, GL, Flege, JB Jr, Wright, CB, et al. Sternotomy infection: poor prediction by acute phase response and delayed hypersensitivity. Ann Thorac Surg 1990;50:949958.CrossRefGoogle ScholarPubMed
14. Gomes, MMR, McGoon, DC. Bleeding patterns after open-heart surgery. J Thorac Cardiovasc Surg 1970;60:8797.CrossRefGoogle ScholarPubMed
15. Harker, LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986;314:14461448. Editorial.Google ScholarPubMed
16. Lambert, CJ, Marengo-Rowe, AJ, Leveson, J, Green, RH, Thiele, JP, Geisler, GF, et al. The treatment of postperfusion bleeding using ξ-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann Thorac Surg 1979;28:440444.CrossRefGoogle Scholar
17. Prentice, C, Orchard, M, Goodchild, C. Haemostatic dysfunction and cardiopulmonary bypass: mechanisms and therapeutic choices. Perfusion 1993;8(suppl):2835.CrossRefGoogle Scholar
18. Woodman, RC, Harker, LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:16801697.CrossRefGoogle ScholarPubMed
19. Villarino, ME, Gordon, SM, Valdon, C, Potts, D, Fish, K, Uyeda, C, et al. A cluster of severe postoperative bleeding following open heart surgery. Infect Control Hosp Epidemiol 1992;13:282287.CrossRefGoogle ScholarPubMed
20. Ovrum, E, Holen, EA, Abdelnoor, M, Oystese, R, Ringdal, ML. Tranexamic acid (cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993;105:7883.CrossRefGoogle Scholar
21. Bagge, L, Lilienberg, G, Nystrom, S-O, Tyden, H. Coagulation, fibrinolysis and bleeding after open-heart surgery. Scand J Thor Cardiovasc Surg 1986;20:151160.Google ScholarPubMed
22. Ferraris, VA, Ferraris, SP, Lough, FC, Berry, WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:7174.CrossRefGoogle ScholarPubMed
23. Michelson, F, Morganroth, J, Torosian, M, MacVaugh, H III. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1978;76:694697.Google Scholar
24. Harker, LA, Malpass, TW, Branson, HE, Hessel, EA II, Slichter, SA. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;56:824834.Google ScholarPubMed
25. Yau, TM, Carson, S, Weisel, RD, Ivanov, J, Sun, Z, Yu, R, et al. The effect of warm heart surgery on postoperative bleeding. J Thorac Cardiovasc Surg 1992;103:11551163.CrossRefGoogle ScholarPubMed
26. Valeri, CR, Cassidy, G, Khuri, S, Feingold, H, Ragno, G, Altschule, MD. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987;205:175181.CrossRefGoogle ScholarPubMed
27. Kuitunen, A, Hynynen, M, Salmenpera, M, Hainonen, J, Vahtera, E, Verkkala, K, et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostatsis. Acta Anaesthesiol Scand 1993;37:652658.CrossRefGoogle Scholar
28. Cope, JT, Banks, D, Mauney, MC, Lucktong, T, Shockey, KS, Kron, IL, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997;63:7883.CrossRefGoogle ScholarPubMed
29. Kestin, AS, Valeri, CR, Khuri, SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107117.CrossRefGoogle ScholarPubMed
30. Palanzo, DA, Parr, GVS, Bull, AP Williams, DR, O'Neill, MJ, Waldhausen, JA. Heatastarch a prime for cardiopulmonary bypass. Ann Thorac Surg 1982;34:680683.CrossRefGoogle ScholarPubMed
31. Saunders, CR, Carlisle, L, Bick, RL. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions. Ann Thorac Surg 1983;36:532539.CrossRefGoogle ScholarPubMed
32. Sade, RM, Stroud, MR, Crawford, FA, Kratz, JM, Dearing, JP, Bartles, DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;89:713722.CrossRefGoogle ScholarPubMed
33. Diehl, JT, Lester, L, Cosgrove, DM. Clinical comparison of het-astarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982;34:674679.CrossRefGoogle ScholarPubMed
34. Kirklin, JK, Lell, WA, Kouchoukos, NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984;37:4046.CrossRefGoogle ScholarPubMed
35. Munsch, CM, MacIntyre, E, Machin, SJ, Mackie, IJ, Treasure, T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 1988;75:675678.CrossRefGoogle ScholarPubMed
36. Strauss, RG. Volume replacement and coagulation: a comparative review. J Cardiothorac Anesth 1988;2:2432, S1.CrossRefGoogle Scholar
37. Taylor, GJ, Mikell, FL, Moses, HW, Dove, JT, Katholi, RE, Malik, SA, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990;65:309313.CrossRefGoogle ScholarPubMed
38. American Heart Association. Heart and Stroke Facts. 1995 Statistical supplement. 1995:21.Google Scholar